Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U2 small nuclear 8, pseudogene (RNU2-8P)** is a human pseudogene that resembles genes encoding the U2 small nuclear RNA, a component of the spliceosome complex responsible for pre-mRNA splicing[1][4]. Unlike its functional counterparts, RNU2-8P is classified as a pseudogene, meaning it does not produce a functional RNA product and has no known biological function or disease association. Pseudogenes such as RNU2-8P typically arise from duplication or retrotransposition events and often contain sequence similarities to their functional parental genes but lack regulatory elements or contain disruptive mutations[4]. There is no evidence to support this as a therapeutic target, a biomarker, or a disease-causing locus. **Notes on correctness:** There is nothing technically misspelled in the name RNU2-8P, but the entity is a **pseudogene, not a protein, receptor, or functional RNA**, and it is not considered a drug target or a receptor. It should be annotated as a non-functional locus and not be included among actionable molecular targets such as enzymes or receptors[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 8, pseudogene (RNU2-8P).